Skip to content

AOT and ICT for Hemiplegia

Action-Observation Therapy (AOT) and Information and Communications Technologies (ICT) for Home Rehabilitation of Hemiplegia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03094455
Acronym
Tele-UPCAT
Enrollment
30
Registered
2017-03-29
Start date
2017-03-29
Completion date
2018-11-29
Last updated
2019-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegia, Hemiplegic Cerebral Palsy

Keywords

Tele-rehabilitation, Action Observation, Mirror neurons, ICT

Brief summary

A new rehabilitative approach, called AOT, based on the recent discovery of mirror neuron system (MNS), has been used with promising results on the Upper Limb (UL) function in some studies in children with Cerebral Palsy (CP).The purpose of the present trial is to provide evidence by a RCT that AOT is an effective rehabilitation tool in Children with Unilateral CP (UCP) and that its effects are greater than standard care. Assisting Hand Assessment is chosen as primary outcome measure and a sample size of 10 per group is required. The rehabilitation lasting 3 weeks will be provided at home by an ICT platform able to deliver, manage, monitor and measure a personalized AOT.

Detailed description

A waitlist control, evaluator-blinded, randomized trial (RCT) will be conducted according to CONSORT guidelines. Each participant will be randomized to either: 1. Immediate intervention group (Experimental group). Children will receive immediately the system for 3 weeks. 2. Waitlist delayed intervention (Control group). Children will continue standard care for 3 weeks and then will receive the system as the Experimental group. As such, all participants will receive the AOT training. The system will provide an in-home, individualized, intensive treatment based on the AOT. The system will be delivered at home and the children will perform a 60-minute training session 5 days a week for 3 consecutive weeks. For the Immediate intervention group, follow-up assessment (outcome measures) will be conducted before (T0) and post-intervention at 3 weeks (T1), and then 8 and 24 weeks after T1(T2 and T3). For the Waitlist group, the assessments will be conducted before T0 and 3 weeks after (T1) the standard care, then they will follow the same timeline of the first group (T1 plus, after the AOT intervention) and 8 and 24 weeks after T1 Puls (T2 and T3). The primary endpoint will be T1. Clinical assessments will be administered by a therapist blind to group assignment in each center. Scoring of videotaped clinical outcome measures will be performed by therapists blind to group allocation and assessment order.

Interventions

OTHERExperimental group

Observation of video sequences showing uni¬manual or bimanual goal-directed actions followed by the execution of the observed actions either with plegic upper limb for unimanual or with both upper limbs for bimanual actions.

Sponsors

BioRobotics Institute
CollaboratorOTHER
IRCCS Fondazione Stella Maris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

It will be a parallel RCT with a waitlist design

Eligibility

Sex/Gender
ALL
Age
5 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

* confirmed diagnosis of spastic UCP * age between 15 and 20 years * predominant spasticity at upper limb upper limb * minimal ability to grasp and hold objects, also passively, with affected hand (House functional classification score 2 or more) * sufficient cooperation, cognitive and communicative understanding to perform assessments and participate in the intervention * subjects and parents able to commit to the intensive therapy program for a period of 3 weeks

Exclusion criteria

* Children who had sustained previous orthopedic surgery or botulinum toxin A injection in the UL within 6 months prior to study entry were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Changes in the Assisting Hand AssessmentBaseline (T0, 1week before beginning of Study) ;T1 (within 1 week after the end of the training/control period); T1 plus (within 1 week after the end of training for waitlist group), T2 and T3 (8weeks after T1 or T1/plus) T3 (16 weeks after T2)This assessment measures upper limb function during bimanual activities. The test evaluates spontaneous use of assisting hand during a semi-structured session with specific toys or tasks with objects requiring bimanual handling

Secondary

MeasureTime frameDescription
Changes in ABILHAND-kidsBaseline (T0, 1week before beginning of Study) ;T1 (within 1 week after the end of the training/control period); T1 plus (within 1 week after the end of training for waitlist group), T2 and T3 (8weeks after T1 or T1/plus) T3 (16 weeks after T2)a semi-structured item-response questionnaire that measures manual ability according to an caregiver's perceived difficulty performing daily bimanual tasks.
Changes in Box and Block TestBaseline (T0, 1week before beginning of Study) ;T1 (within 1 week after the end of the training/control period); T1 plus (within 1 week after the end of training for waitlist group), T2 and T3 (8weeks after T1 or T1/plus) T3 (16 weeks after T2): it measures unilateral gross manual dexterity. It is a quick, simple and inexpensive test. It can be used with a wide range of populations from childhood to adults.
Changes in Melbourne Assessment of Unilateral Upper Limb FunctionBaseline (T0, 1week before beginning of Study) ;T1 (within 1 week after the end of the training/control period); T1 plus (within 1 week after the end of training for waitlist group), T2 and T3 (8weeks after T1 or T1/plus) T3 (16 weeks after T2)It is criterion-referenced test that measures unilateral upper extremity quality of movement in subjects with neurological impairments

Other

MeasureTime frameDescription
Quantitative Changes in upper limbs activities detected with Actigraph GXT3+ during AHABaseline (T0, 1week before beginning of Study); T1 (within 1 week after the end of the training/control period); T1 plus (within 1 week after the end of training for waitlist group), T2 and T3 (8weeks after T1 or T1/plus) T3 (16 weeks after T2)Actigraph GXT3+ worn during AHA assessments
Changes in daily life activities detected with Actigraph GXT3+During training and/or standard period (from T0 to T1 and/or T1 to T1plus) (T0,1week before beginning of Study); T1 (within 1 week after the end of the training/control period); T1 plus (within 1 week after the end of training for waitlist group)Quantitative measurement of daily manual activities
Participation and Environment Measure - Children and Youth (PEM-CY)Baseline (T0) and T3 (16 weeks after T2)it is a measure that evaluates participation in the home, at school, and in the community, alongside environmental factors within each of these settings.
Cerebral Palsy Quality of Life QuestionnaireBaseline (T0) and T3 (16 weeks after T2)These instruments are useful for evaluating interventions designed to improve the lives of children and adolescents
Quantitative measurement of reaching and grasping capabilities by means of a sensorized object that allow different grasping tasksBaseline (T0, 1week before beginning of Study) ;T1 (within 1 week after the end of the training/control period); T1 plus (within 1 week after the end of training for waitlist group), T2 and T3 (8weeks after T1 or T1/plus) T3 (16 weeks after T2)The sensorized object allows to perform three different tasks at increasing level of difficulties (unimanual lifting, bimanual placing near and bimanual cooperation, holding and pulling)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026